Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Moore

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Nature|January 24, 2024
Motion of VAPB molecules reveals ER-mitochondria contact site subdomainsChristopher J Obara, Jonathon Nixon-Abell, Andrew S Moore, et al.
Cancer Letters|September 4, 2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsTeresa Sadras, Susan L Heatley, Chung H Kok, et al.
The Journal of Cell Biology|March 10, 2025
Vimentin filament transport and organization revealed by single-particle tracking and 3D FIB-SEMBhuvanasundar Renganathan, Andrew S Moore, Wei-Hong Yeo, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Nature|March 4, 2021
Actin cables and comet tails organize mitochondrial networks in mitosisAndrew S Moore, Stephen M Coscia, Cory L Simpson, et al.
Cell|December 21, 2024
Periodic ER-plasma membrane junctions support long-range Ca<sup>2+</sup> signal integration in dendritesLorena Benedetti, Ruolin Fan, Aubrey V Weigel, et al.
Journal of Medicinal Chemistry|October 10, 2012
Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemiaVassilios Bavetsias, Simon Crumpler, Chongbo Sun, et al.
Blood Advances|April 14, 2020
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736Andrew S Moore, Amir Faisal, Grace W Y Mak, et al.
Cancers|October 14, 2023
Reproducible Bioinformatics Analysis Workflows for Detecting <i>IGH</i> Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia PatientsAshlee J Thomson, Jacqueline A Rehn, Susan L Heatley, et al.
British Journal of Haematology|February 4, 2020
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 childrenTheodor Uden, Alice Bertaina, Jonas Abrahamsson, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Nature|January 24, 2024
Motion of VAPB molecules reveals ER-mitochondria contact site subdomainsChristopher J Obara, Jonathon Nixon-Abell, Andrew S Moore, et al.
Cancer Letters|September 4, 2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsTeresa Sadras, Susan L Heatley, Chung H Kok, et al.
The Journal of Cell Biology|March 10, 2025
Vimentin filament transport and organization revealed by single-particle tracking and 3D FIB-SEMBhuvanasundar Renganathan, Andrew S Moore, Wei-Hong Yeo, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Nature|March 4, 2021
Actin cables and comet tails organize mitochondrial networks in mitosisAndrew S Moore, Stephen M Coscia, Cory L Simpson, et al.
Cell|December 21, 2024
Periodic ER-plasma membrane junctions support long-range Ca<sup>2+</sup> signal integration in dendritesLorena Benedetti, Ruolin Fan, Aubrey V Weigel, et al.
Journal of Medicinal Chemistry|October 10, 2012
Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemiaVassilios Bavetsias, Simon Crumpler, Chongbo Sun, et al.
Blood Advances|April 14, 2020
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736Andrew S Moore, Amir Faisal, Grace W Y Mak, et al.
Cancers|October 14, 2023
Reproducible Bioinformatics Analysis Workflows for Detecting <i>IGH</i> Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia PatientsAshlee J Thomson, Jacqueline A Rehn, Susan L Heatley, et al.
British Journal of Haematology|February 4, 2020
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 childrenTheodor Uden, Alice Bertaina, Jonas Abrahamsson, et al.
Pageof 9